Bradley D Crow, MD
Orthopedic Surgery · Stanford
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Office
- 1
Offices
1 location · Stanford Health Care · 3,152 clinicians in this group
Looking this up.
Hospitals listed: 059145 · 557290 · Stanford Health Care · Stanford Health Care Tri-Valley. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Crow’s office at (650) 723-4000 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A99249 · Current
Licensed to practise in California · since 2007 · expires 2027-03-31 · Saint Louis University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Stanford Health CareStanford, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency departmentPart of Stanford Health Care, which runs 3 hospitalsHome of Stanford Cancer Institute, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 83% would definitely recommend itOverall rating: 5 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 5.31 (4.24 to 6.37) · 8,661 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 14.1 (12.7 to 15.7) · 2,191 cases, Jan 2024 – Dec 2024Better than the national rate — Postoperative respiratory failure rate: 4.08 (1.95 to 6.21) · 5,296 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.317, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.446, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.241, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.7 (0.6 to 0.9) · 3,348 cases, Jan 2024 – Dec 2024
- Stanford Health Care Tri-ValleyPleasanton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Stanford Health Care, which runs 3 hospitalsPatients rate it 3 of 5 · 74% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.178, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.237, Oct 2024 – Sep 2025
See every measure and the patient survey for Stanford Health Care
Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 2 better, 5 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 5.31 (4.24 to 6.37) · 8,661 cases | Worse | Jul 2022 – Jun 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 14.1 (12.7 to 15.7) · 2,191 cases | Worse | Jan 2024 – Dec 2024 |
| Postoperative respiratory failure rateComplications and deaths | 4.08 (1.95 to 6.21) · 5,296 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.317 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.446 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.241 | Better | Oct 2024 – Sep 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.7 (0.6 to 0.9) · 3,348 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.06 (0.45 to 1.67) · 5,374 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.86 (0.72 to 1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.09 (137.88 to 194.3) · 470 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.1 · 192 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 146 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 9.7 · 253 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 6.3 · 880 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 935 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 8.7 · 501 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.1 · 7,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.13 (0 to 0.27) · 20,799 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.14 to 0.43) · 23,182 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.94 (0.2 to 1.68) · 5,694 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.36 (1.54 to 3.19) · 7,846 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.2 (3.76 to 6.64) · 5,603 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.38 (0.23 to 2.53) · 2,211 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.52 (0.21 to 0.83) · 19,915 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.6 · 416 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.869 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.857 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.368 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 16.2 · 247 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.5 · 1,021 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 47.8 · 258 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -1.6 · 990 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 976 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.5 · 959 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.4 to 6.2) · 2,191 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 425 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.6 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.6 · 183 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.7 (10.4 to 15.4) · 4,578 cases | No different | Jan 2022 – Dec 2024 |
What patients said (6,810 patients answered, 25% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 82% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 76% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 83% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for Stanford Health Care Tri-Valley
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 2 better, 7 the same, 0 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.178 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.237 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.79 (0 to 1.73) · 1,041 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.79 (0.5 to 1.08) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 145.81 (96.5 to 195.12) · 72 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.9 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.6 · 92 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.5 · 96 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.5 · 395 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 10.3 · 391 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 162 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 1,736 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 4,425 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.22 (0.02 to 0.41) · 4,771 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.46 to 5.44) · 1,403 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.5 (0.05 to 2.94) · 645 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.81 (0.38 to 3.24) · 1,279 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.53 (3.2 to 13.85) · 639 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.15 (1.89 to 8.41) · 648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.14 to 3.07) · 370 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.83) · 4,160 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4 · 74 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.369 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.112 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.1 · 110 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.1 · 437 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -5.8 · 94 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -19.3 · 456 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.3 · 402 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.8 · 358 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6.8 (4.7 to 9.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.1 (7.5 to 13.6) · 198 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.3 · 80 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.9 · 46 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.3 · 92 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.4 (9.6 to 16.2) · 1,532 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.2) · 929 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,268 patients answered, 26% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 65% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 42% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$305,002
Medicare paid this office $305,002 for 536 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Replacement of knee joint, both sides of knee | 118 | $139,865 | $1,156 |
| Replacement of thigh bone and hip joint with prosthesis | 61 | $71,099 | $1,147 |
| Short return visit (20+ min) | 227 | $22,328 | $80 |
| Return visit (30+ min) | 125 | $14,211 | $109 |
| New patient visit (30+ min) | 155 | $14,189 | $92 |
See all 13 services
| Replacement of knee joint, both sides of knee | 118 | $139,865 | $1,156 |
| Replacement of thigh bone and hip joint with prosthesis | 61 | $71,099 | $1,147 |
| Short return visit (20+ min) | 227 | $22,328 | $80 |
| Return visit (30+ min) | 125 | $14,211 | $109 |
| New patient visit (30+ min) | 155 | $14,189 | $92 |
| Aspiration and/or injection of fluid from large joint | 56 | $4,298 | $68 |
| Telephone medical discussion with physician, 11-20 minutes | 38 | $3,395 | $83 |
| Telephone medical discussion with physician, 5-10 minutes | 25 | $1,368 | $53 |
| Short return visit | 24 | $1,216 | $51 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 22 | $311 | $14 |
| Injection, methylprednisolone acetate, 1 mg | 20 | $173 | None |
| Injection, methylprednisolone acetate, 40 mg | 17 | $161 | None |
| Injection, bupivicaine, not otherwise specified, 0.5 mg | 16 | $3 | None |
Procedures Medicare counted
| Hip replacement | 82 | More than 95% of doctors who do this |
| Knee replacement | 129 | More than 96% of doctors who do this |
Who their Medicare patients are
536 Original Medicare patients in 2024. Average age 74 · Under 65 4% · 85 and older 6% · Women 64% · Also on Medicaid 15% · Health risk score 1.04. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 1.13.
Conditions among them: High blood pressure 75% · Chronic kidney disease 25% · Diabetes 21% · Depression 21% · Coronary heart disease 20% · Cancer 18% · Atrial fibrillation 17% · COPD 13% · Heart failure 12% · Stroke 6% · Dementia 4%.
The office billed $2,630,477, Medicare allowed $393,153 and paid $305,002; for 4,288 services of 33 kinds; $14,424 of it was for drugs given in the office and $290,578 for care.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 536 | 4,288 | 74 | 1.04 | $2,630,477 | $305,002 |
| 2023 | 463 | 1,946 | 74 | 0.95 | $1,449,491 | $218,623 |
| 2022 | 640 | 2,473 | 74 | 1.00 | $1,229,185 | $326,158 |
| 2021 | 541 | 2,328 | 74 | 1.05 | $637,388 | $242,021 |
| 2020 | 522 | 1,796 | 74 | 1.14 | $678,960 | $247,648 |
| 2019 | 569 | 2,192 | 73 | 1.18 | $781,092 | $285,136 |
| 2018 | 551 | 2,782 | 73 | 1.18 | $776,000 | $277,028 |
| 2017 | 518 | 4,233 | 73 | 1.26 | $717,198 | $244,849 |
| 2016 | 487 | 2,309 | 73 | 1.24 | $763,563 | $255,292 |
| 2015 | 408 | 2,204 | 73 | 1.35 | $671,150 | $223,480 |
| 2014 | 374 | 2,363 | 73 | 1.11 | $613,283 | $207,122 |
| 2013 | 367 | 2,154 | 73 | 1.17 | $576,888 | $194,722 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Replacement of knee joint, both sides of knee | 76 | $86,313 | $1,136 |
| Replacement of thigh bone and hip joint with prosthesis | 28 | $34,558 | $1,152 |
| Short return visit (20+ min) | 216 | $18,915 | $68 |
| Return visit (30+ min) | 102 | $13,369 | $117 |
| New patient visit (30+ min) | 96 | $8,879 | $92 |
| Long return visit (40+ min) | 28 | $4,480 | $160 |
| New patient visit (45+ min) | 30 | $4,251 | $142 |
| Aspiration and/or injection of fluid from large joint | 57 | $3,538 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 18 | $1,541 | $81 |
| X-ray of hip, 2-3 views | 29 | $1,228 | $37 |
| Short return visit | 34 | $1,174 | $35 |
| X-ray of knee, 4 or more views | 27 | $1,166 | $28 |
| X-ray of knee, 3 views | 35 | $1,121 | $28 |
| Telephone medical discussion with physician, 5-10 minutes | 18 | $960 | $51 |
| Telehealth originating site facility fee | 34 | $943 | $22 |
| Injection, methylprednisolone acetate, 40 mg | 36 | $395 | None |
2022: 19 services
| Replacement of knee joint, both sides of knee | 107 | $130,831 | $1,148 |
| Replacement of thigh bone and hip joint with prosthesis | 50 | $58,586 | $1,127 |
| Short return visit (20+ min) | 359 | $37,123 | $82 |
| Return visit (30+ min) | 126 | $15,447 | $119 |
| New patient visit (30+ min) | 112 | $11,623 | $104 |
| X-ray of knee, 4 or more views | 154 | $10,569 | $48 |
| Aspiration and/or injection of fluid from large joint | 124 | $9,902 | $66 |
| X-ray of hip, 2-3 views | 115 | $6,967 | $47 |
| X-ray of knee, 3 views | 101 | $5,643 | $41 |
| Mri scan of leg joint without contrast | 28 | $4,780 | $159 |
| Short return visit | 79 | $4,622 | $52 |
| Mri scan of lower spinal canal without contrast | 18 | $2,481 | $138 |
| X-ray of both hips, 3-4 views | 23 | $1,336 | $56 |
| Injection, methylprednisolone acetate, 40 mg | 69 | $911 | None |
| X-ray of knee, 1-2 views | 19 | $823 | $34 |
| X-ray of pelvis, 1-2 views | 17 | $487 | $29 |
| Telephone medical discussion with physician, 5-10 minutes | 11 | $393 | $36 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 47 | $369 | None |
| Injection, methylprednisolone acetate, 80 mg | 14 | $169 | None |
2021: 17 services
| Replacement of knee joint, both sides of knee | 66 | $83,185 | $1,155 |
| Replacement of thigh bone and hip joint with prosthesis | 36 | $42,455 | $1,147 |
| Short return visit (20+ min) | 336 | $33,263 | $78 |
| Return visit (30+ min) | 99 | $10,804 | $105 |
| New patient visit (30+ min) | 88 | $8,319 | $95 |
| Aspiration and/or injection of fluid from large joint | 104 | $7,679 | $60 |
| X-ray of knee, 4 or more views | 125 | $7,210 | $45 |
| X-ray of hip, 2-3 views | 106 | $5,870 | $46 |
| X-ray of knee, 3 views | 93 | $5,032 | $39 |
| Mri scan of leg joint without contrast | 18 | $3,169 | $167 |
| Short return visit | 40 | $2,044 | $46 |
| New patient visit (45+ min) | 11 | $1,254 | $114 |
| Injection, methylprednisolone acetate, 40 mg | 88 | $1,051 | None |
| X-ray of both hips, 3-4 views | 14 | $730 | $52 |
| X-ray of knee, 1-2 views | 12 | $568 | $35 |
| X-ray of pelvis, 1-2 views | 13 | $342 | $26 |
| Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 11 | $57 | None |
2020: 19 services
| Replacement of knee joint, both sides of knee | 72 | $93,143 | $1,210 |
| Replacement of thigh bone and hip joint with prosthesis | 36 | $46,962 | $1,204 |
| Short return visit (20+ min) | 310 | $26,675 | $63 |
| New patient visit (30+ min) | 119 | $10,823 | $91 |
| Return visit (30+ min) | 87 | $8,640 | $96 |
| Aspiration and/or injection of fluid from large joint | 106 | $6,809 | $57 |
| X-ray of knee, 3 views | 119 | $5,763 | $36 |
| X-ray of hip, 2-3 views | 89 | $5,066 | $45 |
| Mri scan of leg joint without contrast | 27 | $4,516 | $161 |
| X-ray of knee, 4 or more views | 81 | $4,209 | $43 |
| Mri scan of lower spinal canal without contrast | 16 | $2,127 | $133 |
| Short return visit | 45 | $1,688 | $34 |
| X-ray of both knees while standing | 25 | $1,004 | $40 |
| Injection, methylprednisolone acetate, 40 mg | 102 | $949 | None |
| X-ray of knee, 1-2 views | 14 | $617 | $32 |
| X-ray of pelvis, 1-2 views | 22 | $588 | $27 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 12 | $561 | $47 |
| X-ray of pelvis, minimum of 3 views | 11 | $455 | $41 |
| X-ray of lower and sacral spine, 2-3 views | 11 | $350 | $32 |
2019: 19 services
| Replacement of knee joint, both sides of knee | 77 | $98,961 | $1,222 |
| Replacement of thigh bone and hip joint with prosthesis | 43 | $52,129 | $1,185 |
| Short return visit (20+ min) | 358 | $33,863 | $65 |
| New patient visit (30+ min) | 119 | $10,878 | $91 |
| Aspiration and/or injection of fluid from large joint | 140 | $9,768 | $60 |
| X-ray of knee, 3 views | 163 | $8,807 | $36 |
| Return visit (30+ min) | 74 | $7,225 | $98 |
| Mri scan of leg joint without contrast | 32 | $6,043 | $173 |
| X-ray of hip, 2-3 views | 116 | $6,031 | $41 |
| X-ray of knee, 4 or more views | 74 | $3,479 | $41 |
| Mri scan of lower spinal canal without contrast | 16 | $2,256 | $141 |
| Short return visit | 44 | $1,934 | $39 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 27 | $1,373 | $51 |
| Injection, methylprednisolone acetate, 40 mg | 130 | $1,354 | None |
| X-ray of both hips, 3-4 views | 23 | $1,166 | $51 |
| X-ray of both knees while standing | 26 | $955 | $37 |
| X-ray of pelvis, 1-2 views | 22 | $822 | $32 |
| X-ray of knee, 1-2 views | 17 | $699 | $29 |
| Aspiration and/or injection of fluid from large joint | 11 | $630 | $33 |
2018: 19 services
| Replacement of knee joint, both sides of knee | 71 | $92,265 | $1,153 |
| Replacement of thigh bone and hip joint with prosthesis | 49 | $60,486 | $1,141 |
| Short return visit (20+ min) | 358 | $27,454 | $59 |
| New patient visit (30+ min) | 122 | $10,320 | $85 |
| Aspiration and/or injection of fluid from large joint | 151 | $10,092 | $53 |
| X-ray of knee, 3 views | 130 | $6,440 | $32 |
| X-ray of hip, 2-3 views | 103 | $5,587 | $38 |
| Return visit (30+ min) | 41 | $3,795 | $93 |
| Mri scan of leg joint without contrast | 18 | $3,321 | $144 |
| X-ray of knee, 4 or more views | 73 | $2,970 | $36 |
| Short return visit | 67 | $2,943 | $40 |
| X-ray of knee, 1-2 views | 38 | $1,501 | $30 |
| Injection, methylprednisolone acetate, 40 mg | 127 | $1,242 | None |
| X-ray of both knees while standing | 32 | $1,042 | $33 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 16 | $830 | $49 |
| X-ray of both hips, 3-4 views | 15 | $656 | $44 |
| Aspiration and/or injection of fluid from large joint | 15 | $632 | $39 |
| X-ray of pelvis, 1-2 views | 15 | $460 | $31 |
| Fluoroscopic guidance for needle placement | 12 | $313 | $24 |
2017: 18 services
| Replacement of knee joint, both sides of knee | 81 | $98,991 | $1,125 |
| Replacement of thigh bone and hip joint with prosthesis | 35 | $40,009 | $1,143 |
| Short return visit (20+ min) | 311 | $25,631 | $60 |
| New patient visit (30+ min) | 132 | $10,888 | $82 |
| Aspiration and/or injection of fluid from large joint | 130 | $9,681 | $45 |
| X-ray of knee, 3 views | 134 | $5,933 | $32 |
| Short return visit | 147 | $5,423 | $31 |
| X-ray of hip, 2-3 views | 86 | $4,302 | $37 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 15 | $3,059 | None |
| Mri scan of leg joint without contrast | 17 | $2,997 | $136 |
| X-ray of knee, 4 or more views | 73 | $2,985 | $36 |
| Mri scan of lower spinal canal without contrast | 12 | $1,616 | $135 |
| Injection, methylprednisolone acetate, 40 mg | 117 | $1,291 | None |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 23 | $1,190 | $46 |
| X-ray of both knees while standing | 22 | $711 | $32 |
| X-ray of knee, 1-2 views | 20 | $644 | $25 |
| X-ray of both hips, 2 views | 12 | $485 | $37 |
| X-ray of pelvis, 1-2 views | 12 | $329 | $27 |
2016: 17 services
| Replacement of knee joint, both sides of knee | 71 | $89,220 | $1,159 |
| Replacement of thigh bone and hip joint with prosthesis | 29 | $32,970 | $1,099 |
| Short return visit (20+ min) | 233 | $16,054 | $59 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 39 | $13,114 | None |
| Aspiration and/or injection of fluid from large joint | 157 | $13,022 | $46 |
| Short return visit | 204 | $9,693 | $34 |
| New patient visit (30+ min) | 88 | $7,396 | $84 |
| X-ray of knee, 3 views | 96 | $4,423 | $31 |
| X-ray of hip, 2-3 views | 66 | $3,266 | $36 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,642 | $115 |
| X-ray of knee, 4 or more views | 45 | $1,580 | $34 |
| Aspiration and/or injection of fluid from large joint | 24 | $1,127 | $36 |
| Injection, methylprednisolone acetate, 40 mg | 116 | $1,065 | None |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 20 | $951 | $48 |
| X-ray of both knees while standing | 26 | $834 | $32 |
| X-ray of knee, 1-2 views | 19 | $577 | $26 |
| Fluoroscopic guidance for needle placement | 18 | $543 | $26 |
2015: 18 services
| Replacement of knee joint, both sides of knee | 46 | $58,316 | $1,166 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 49 | $32,983 | None |
| Replacement of thigh bone and hip joint with prosthesis | 25 | $31,321 | $1,160 |
| Aspiration and/or injection of fluid from large joint | 131 | $19,542 | $57 |
| Short return visit | 229 | $12,333 | $35 |
| Short return visit (20+ min) | 117 | $8,792 | $60 |
| New patient visit (30+ min) | 101 | $8,489 | $84 |
| X-ray of knee, 3 views | 77 | $3,463 | $30 |
| X-ray of ribs of one side of body, minimum of 2 views | 70 | $3,400 | $32 |
| X-ray of knee, 1-2 views | 87 | $2,929 | $25 |
| Return visit (30+ min) | 22 | $1,886 | $86 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 13 | $1,108 | $85 |
| Injection of contrast for imaging of hip joint | 17 | $1,055 | $59 |
| Injection, methylprednisolone acetate, 40 mg | 99 | $894 | None |
| Fluoroscopic guidance for needle placement | 18 | $617 | $32 |
| X-ray of pelvis, 1-2 views | 15 | $378 | $25 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 19 | $330 | $17 |
| Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 12 | $65 | None |
2014: 17 services
| Replacement of knee joint, both sides of knee | 37 | $44,607 | $1,144 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 61 | $33,403 | None |
| Replacement of thigh bone and hip joint with prosthesis | 21 | $24,590 | $1,171 |
| Aspiration and/or injection of fluid from large joint | 164 | $21,600 | $53 |
| Short return visit | 241 | $13,414 | $35 |
| New patient visit (30+ min) | 108 | $9,022 | $84 |
| Short return visit (20+ min) | 105 | $7,547 | $60 |
| X-ray of knee, 3 views | 65 | $3,398 | $33 |
| Return visit (30+ min) | 35 | $3,353 | $93 |
| X-ray of knee, 1-2 views | 87 | $3,096 | $27 |
| X-ray of ribs of one side of body, minimum of 2 views | 59 | $2,925 | $34 |
| Mri scan of leg joint without contrast | 11 | $2,160 | $180 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 16 | $1,381 | $86 |
| Injection, methylprednisolone acetate, 40 mg | 124 | $830 | None |
| Aspiration and/or injection of fluid from large joint | 18 | $737 | $37 |
| X-ray of pelvis, 1-2 views | 18 | $448 | $25 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 21 | $334 | $16 |
2013: 22 services
| Replacement of knee joint, both sides of knee | 35 | $46,917 | $1,268 |
| Replacement of thigh bone and hip joint with prosthesis | 24 | $30,671 | $1,227 |
| Aspiration and/or injection of fluid from large joint | 139 | $15,674 | $47 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 37 | $15,456 | None |
| Short return visit | 206 | $12,556 | $37 |
| New patient visit (30+ min) | 136 | $11,731 | $86 |
| Short return visit (20+ min) | 104 | $7,753 | $60 |
| Hyaluronan or derivative, orthovisc, for intra-articular injection, per dose | 13 | $4,840 | None |
| X-ray of knee, 1-2 views | 103 | $3,849 | $29 |
| Mri scan of lower spinal canal without contrast | 11 | $3,356 | $305 |
| X-ray of knee, 3 views | 55 | $3,055 | $35 |
| Mri scan of leg joint without contrast | 13 | $2,754 | $212 |
| Return visit (30+ min) | 25 | $2,168 | $87 |
| X-ray of pelvis, 1-2 views | 57 | $2,135 | $26 |
| Computer-assisted surgery for muscle and bone procedure | 13 | $1,600 | $123 |
| X-ray of hip on one side of body, 1 view | 45 | $1,542 | $25 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 11 | $881 | $80 |
| X-ray of ribs of one side of body, minimum of 2 views | 20 | $769 | $35 |
| Aspiration and/or injection of fluid from large joint | 18 | $704 | $37 |
| Injection, methylprednisolone acetate, 40 mg | 103 | $581 | None |
| Fluoroscopic guidance for needle placement | 15 | $448 | $26 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 25 | $438 | $16 |
Drugs they prescribed that Part D paid
$3,196
Pharmacies billed $3,196 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 18% of their Part D prescriptions (59 of 338) in 2024. At or below the middle of the specialty; the typical orthopedic surgery clinician is at 31%.
334 generic and fewer than 11 brand-name prescriptions · $3,196 in drug cost · 189 antibiotic prescriptions to 170 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Celecoxib | 15 | $584 | $39 |
| Amoxicillin | 157 | $324 | $2 |
| Oxycodone | 31 | $238 | $8 |
| Tramadol | 16 | $174 | $11 |
| Gabapentin | 20 | $174 | $9 |
See all 8 drugs
| Celecoxib | 15 | $584 | $39 |
| Amoxicillin | 157 | $324 | $2 |
| Oxycodone | 31 | $238 | $8 |
| Tramadol | 16 | $174 | $11 |
| Gabapentin | 20 | $174 | $9 |
| Diclofenac | 11 | $157 | $14 |
| Clindamycin | 25 | $77 | $3 |
| Cyclobenzaprine | 11 | $59 | $5 |
Year by year
| 2024 | 338 | 202 | 18% (59) | None | $3,196 |
| 2023 | 282 | 160 | 16% (44) | None | $4,890 |
| 2022 | 423 | 197 | 24% (103) | None | $7,672 |
| 2021 | 367 | 173 | 18% (66) | None | $5,515 |
| 2020 | 525 | 212 | 24% (125) | None | $12,369 |
| 2019 | 459 | 217 | 32% (146) | 6% | $16,119 |
| 2018 | 494 | 229 | 44% (219) | 10% | $15,504 |
| 2017 | 436 | 209 | 38% (166) | 5% | $9,903 |
| 2016 | 333 | 169 | 43% (142) | 9% | $11,894 |
| 2015 | 302 | 124 | 44% (132) | 19% | $12,655 |
| 2014 | 371 | 119 | 55% (205) | 16% | $14,327 |
| 2013 | 551 | 136 | 64% (350) | 9% | $19,527 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 7 drugs
| Gabapentin | 21 | $446 | $21 |
| Celecoxib | 19 | $408 | $21 |
| Diclofenac | 28 | $367 | $13 |
| Amoxicillin | 108 | $230 | $2 |
| Tramadol | 20 | $118 | $6 |
| Oxycodone | 13 | $102 | $8 |
| Clindamycin | 19 | $83 | $4 |
2022: 11 drugs
| Celecoxib | 41 | $1,579 | $39 |
| Diclofenac | 59 | $884 | $15 |
| Gabapentin | 42 | $422 | $10 |
| Tramadol | 71 | $325 | $5 |
| Baclofen | 12 | $220 | $18 |
| Amoxicillin | 79 | $205 | $3 |
| Cyclobenzaprine | 19 | $199 | $10 |
| Oxycodone | 15 | $177 | $12 |
| Hydrocodone-Acetaminophen | 11 | $171 | $16 |
| Meloxicam | 15 | $157 | $10 |
| Clindamycin | 14 | $85 | $6 |
2021: 8 drugs
| Diclofenac | 68 | $2,451 | $36 |
| Celecoxib | 56 | $1,525 | $27 |
| Hydrocodone-Acetaminophen | 16 | $250 | $16 |
| Gabapentin | 38 | $238 | $6 |
| Tramadol | 34 | $179 | $5 |
| Amoxicillin | 58 | $155 | $3 |
| Cyclobenzaprine | 19 | $105 | $6 |
| Meloxicam | 26 | $98 | $4 |
2020: 10 drugs
| Diclofenac | 118 | $6,849 | $58 |
| Celecoxib | 51 | $1,641 | $32 |
| Tramadol | 78 | $434 | $6 |
| Gabapentin | 38 | $299 | $8 |
| Cyclobenzaprine | 27 | $271 | $10 |
| Amoxicillin | 74 | $215 | $3 |
| Hydrocodone-Acetaminophen | 19 | $181 | $10 |
| Acetaminophen-Codeine | 15 | $119 | $8 |
| Naproxen | 14 | $79 | $6 |
| Pantoprazole | 11 | $31 | $3 |
2019: 7 drugs
| Diclofenac | 97 | $5,380 | $55 |
| Hydrocodone-Acetaminophen | 46 | $867 | $19 |
| Cyclobenzaprine | 23 | $492 | $21 |
| Tramadol | 64 | $475 | $7 |
| Gabapentin | 28 | $292 | $10 |
| Amoxicillin | 80 | $248 | $3 |
| Oxycodone-Acetaminophen | 11 | $237 | $22 |
2018: 11 drugs
| Diclofenac | 75 | $4,692 | $63 |
| Voltaren | 17 | $2,504 | $147 |
| Hydrocodone-Acetaminophen | 91 | $2,057 | $23 |
| Oxycodone | 39 | $790 | $20 |
| Oxycodone-Acetaminophen | 23 | $564 | $25 |
| Tramadol | 42 | $478 | $11 |
| Amoxicillin | 72 | $252 | $3 |
| Hydromorphone | 12 | $125 | $10 |
| Gabapentin | 11 | $113 | $10 |
| Clindamycin | 21 | $100 | $5 |
| Meloxicam | 11 | $68 | $6 |
2017: 9 drugs
| Hydrocodone-Acetaminophen | 79 | $1,895 | $24 |
| Diclofenac | 47 | $1,391 | $30 |
| Oxycodone-Acetaminophen | 31 | $1,276 | $41 |
| Polyethylene Glycol 3350 | 37 | $946 | $26 |
| Celecoxib | 12 | $613 | $51 |
| Cyclobenzaprine | 21 | $491 | $23 |
| Amoxicillin | 66 | $268 | $4 |
| Tramadol | 33 | $178 | $5 |
| Clindamycin | 11 | $71 | $6 |
2016: 8 drugs
| Celecoxib | 14 | $1,875 | $134 |
| Hydrocodone-Acetaminophen | 59 | $1,779 | $30 |
| Oxycodone-Acetaminophen | 37 | $1,520 | $41 |
| Diclofenac | 31 | $804 | $26 |
| Hydromorphone | 11 | $232 | $21 |
| Amoxicillin | 52 | $210 | $4 |
| Tramadol | 28 | $147 | $5 |
| Cyclobenzaprine | 13 | $103 | $8 |
2015: 8 drugs
| Xarelto | 18 | $3,797 | $211 |
| Celecoxib | 18 | $2,403 | $134 |
| Hydrocodone-Acetaminophen | 59 | $1,143 | $19 |
| Oxycodone-Acetaminophen | 38 | $1,114 | $29 |
| Cyclobenzaprine | 18 | $326 | $18 |
| Diclofenac | 13 | $197 | $15 |
| Amoxicillin | 46 | $147 | $3 |
| Tramadol | 20 | $118 | $6 |
2014: 9 drugs
| Xarelto | 26 | $3,710 | $143 |
| Celebrex | 12 | $3,588 | $299 |
| Hydrocodone-Acetaminophen | 125 | $2,028 | $16 |
| Oxycodone-Acetaminophen | 33 | $972 | $29 |
| Diclofenac | 16 | $330 | $21 |
| Tramadol | 24 | $175 | $7 |
| Gabapentin | 12 | $132 | $11 |
| Amoxicillin | 31 | $111 | $4 |
| Clindamycin | 13 | $97 | $7 |
2013: 9 drugs
| Hydrocodone-Acetaminophen | 269 | $5,057 | $19 |
| Celebrex | 12 | $4,868 | $406 |
| Xarelto | 17 | $2,604 | $153 |
| Diclofenac | 17 | $441 | $26 |
| Oxycodone-Acetaminophen | 25 | $348 | $14 |
| Acetaminophen-Codeine | 19 | $248 | $13 |
| Tramadol | 18 | $238 | $13 |
| Amoxicillin | 52 | $184 | $4 |
| Zolpidem | 22 | $98 | $4 |
Money from drug and device companies
$182 in 2025
| 2025 | 1 | 1 | None | $182 |
| 2023 | 2 | 7 | None | $811 |
| 2022 | 4 | 5 | None | $295 |
| 2021 | 4 | 6 | None | $292 |
| 2020 | 1 | 1 | None | $62 |
| 2019 | 4 | 7 | None | $345 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Zimmer Biomet Holdings | None | $182 | 1 payment
|
See the published payment
| Zimmer Biomet Holdings | Meals · 2025-10-30 | None | $182 |
See earlier years (2023, 2022, 2021, 2020, 2019)
2023: $811
| Zimmer Biomet Holdings | Rosa | $675 | 6 payments
|
| MicroPort Orthopedics | Mpo Medial Pivot Knee | $136 | 1 payment
|
2022: $295
| Pacira Pharmaceuticals | Iovera | $140 | 1 payment
|
| Zimmer Biomet Holdings | Rosa | $117 | 2 payments
|
| Medical Device Business Services | None | $24 | 1 payment
|
| Heraeus Medical | Palacos | $15 | 1 payment
|
2021: $292
| Heron Therapeutics | Zynrelef | $152 | 3 payments
|
| Zimmer Biomet Holdings | Rosa-Knee | $80 | 1 payment
|
| Alphatec Spine | None | $44 | 1 payment
|
| Ethicon US | Echelon Circular | $16 | 1 payment
|
2020: $62
| Biocomposites | Stimulan | $62 | 1 payment
|
2019: $345
| Zimmer Biomet Holdings | Avenir | $202 | 2 payments
|
| Medical Device Business Services | Reclaim | $104 | 3 payments
|
| Team_Makena_LLC | None | $20 | 1 payment
|
| Wright Medical Technology | Ortholoc | $18 | 1 payment
|
Checkups this office reported
1 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Risk-standardized complication rate (RSCR) following elective primary total hip arthroplasty (THA) and/or total knee arthroplasty (TKA) for Merit-based Incentive Payment System (MIPS)As Medicare defines this measure | 0% | None |
Professional record
- NPI
- 1811920796
- Licence
- CA A99249California A99249: Current · expires 2027-03-31
- Trained
- Saint Louis University School of Medicine, 2001
- Group
- Stanford Health Care
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Medicaid ID
- MO 200459709
- Taxonomy
- Federal specialty code 207XS0114X (207XS0114X); Orthopedic surgery (207X00000X)
- Mailing address
- 300 Pasteur Dr, Stanford, CA, 94305
- NPI first listed
- 2006-07-07
- NPI last updated
- 2024-04-27
- NPI record certified
- 2024-04-27
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 1800 Sutter St Ste 100, Concord, CA, 94520